The use of genetic tests to diagnose and manage patients with myeloproliferative and myeloproliferative/myelodysplastic neoplasms, and related disorders

被引：12

作者：

Cross, Nicholas C. P. ^{[1
,2
]}

Godfrey, Anna L. ^{[3
]}

Cargo, Catherine ^{[4
]}

Garg, Mamta ^{[5
]}

Mead, Adam J. ^{[6
]}

机构：

[1] Salisbury Dist Hosp, Wessex Reg Genet Lab, Salisbury, Wilts, England

[2] Univ Southampton, Fac Med, Southampton, Hants, England

[3] Cambridge Univ Hosp NHS Fdn Trust, Haematopathol & Oncol Diagnost Serv, Cambridge, England

[4] St James Univ Hosp, Leeds Canc Ctr, Haematol Malignancy Diagnost Serv, Leeds, W Yorkshire, England

[5] Leicester Royal Infirm, Infirm Sq, Leicester, Leics, England

[6] Univ Oxford, John Radcliffe Hosp, NIHR Oxford Biomed Res Ctr, MRC Weatherall Inst Mol Med,MRC Mol Haematol Unit, Oxford, England

来源：

BRITISH JOURNAL OF HAEMATOLOGY | 2021年 / 195卷 / 03期

基金：

奥地利科学基金会; 英国医学研究理事会;

关键词：

myeloproliferative neoplasms; myelodysplastic; mastocytosis; eosinophilia; chronic myelomonocytic leukaemia; STEM-CELL TRANSPLANTATION; CHRONIC MYELOID-LEUKEMIA; AGE-RELATED MUTATIONS; JAK2 V617F MUTATION; ESSENTIAL THROMBOCYTHEMIA; POLYCYTHEMIA-VERA; SOMATIC MUTATIONS; CLONAL HEMATOPOIESIS; CALR MUTATIONS; ALLELE BURDEN;

D O I：

10.1111/bjh.17766

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

[No abstract available]

引用

页码：338 / 351

页数：14

共 130 条

[51] The impact of JAK2 and MPL mutations on diagnosis and prognosis of splanchnic vein thrombosis: a report on 241 cases [J].

Kiladjian, Jean-Jacques ;

Cervantes, Francisco ;

Leebeek, Franck W. G. ;

Marzac, Christophe ;

Cassinat, Bruno ;

Chevret, Sylvie ;

Cazals-Hatem, Dominique ;

Plessier, Aurelie ;

Garcia-Pagan, Juan-Carlos ;

Murad, Sarwa Darwish ;

Raffa, Sebastian ;

Janssen, Harry L. A. ;

Gardin, Claude ;

Cereja, Sophie ;

Tonetti, Carole ;

Giraudier, Stephane ;

Condat, Bertrand ;

Casadevall, Nicole ;

Fenaux, Pierre ;

Valla, Dominique C. .

BLOOD, 2008, 111 (10) :4922-4929

[52] Clinical correlates of JAK2V617F allele burden in essential thrombocythemia [J].

Kittur, Jaya ;

Knudson, Ryan A. ;

Lasho, Terra L. ;

Finke, Christy M. ;

Gangat, Naseema ;

Wolanskyj, Alexandra P. ;

Li, Chin-Yang ;

Wu, Wenting ;

Ketterling, Rhett P. ;

Pardanani, Animesh ;

Tefferi, Ayalew .

CANCER, 2007, 109 (11) :2279-2284

[53] A Highly Sensitive Quantitative Real-Time PCR Assay for Determination of Mutant JAK2 Exon 12 Allele Burden [J].

Kjaer, Lasse ;

Westman, Maj ;

Riley, Caroline Hasselbalch ;

Hogdall, Estrid ;

Bjerrum, Ole Weis ;

Hasselbalch, Hans .

PLOS ONE, 2012, 7 (03)

[54] Somatic Mutations of Calreticulin in Myeloproliferative Neoplasms [J].

Klampfl, Thorsten ;

Gisslinger, Heinz ;

Harutyunyan, Ashot S. ;

Nivarthi, Harini ;

Rumi, Elisa ;

Milosevic, Jelena D. ;

Them, Nicole C. C. ;

Berg, Tiina ;

Gisslinger, Bettina ;

Pietra, Daniela ;

Chen, Doris ;

Vladimer, Gregory I. ;

Bagienski, Klaudia ;

Milanesi, Chiara ;

Casetti, Ilaria Carola ;

Sant'Antonio, Emanuela ;

Ferretti, Virginia ;

Elena, Chiara ;

Schischlik, Fiorella ;

Cleary, Ciara ;

Six, Melanie ;

Schalling, Martin ;

Schoenegger, Andreas ;

Bock, Christoph ;

Malcovati, Luca ;

Pascutto, Cristiana ;

Superti-Furga, Giulio ;

Cazzola, Mario ;

Kralovics, Robert .

NEW ENGLAND JOURNAL OF MEDICINE, 2013, 369 (25) :2379-2390

[55] JAK2-V617F mutation in a patient with Philadelphia-chromosome-positive chronic myeloid leukaemia [J].

Kraemer, Alwin ;

Reiter, Andreas ;

Kruth, Jens ;

Erben, Philipp ;

Hochhaus, Andreas ;

Mueller, Martin ;

Cross, Nicholas C. P. ;

Jones, Amy V. ;

Ho, Anthony D. ;

Hensel, Manfred .

LANCET ONCOLOGY, 2007, 8 (07) :658-660

[56] Sensitive KIT D816V mutation analysis of blood as a diagnostic test in mastocytosis [J].

Kristensen, Thomas ;

Vestergaard, Hanne ;

Bindslev-Jensen, Carsten ;

Moller, Michael Boe ;

Broesby-Olsen, Sigurd .

AMERICAN JOURNAL OF HEMATOLOGY, 2014, 89 (05) :493-498

[57] Indication and management of allogeneic stem cell transplantation in primary myelofibrosis: a consensus process by an EBMT/ELN international working group [J].

Kroeger, N. M. ;

Deeg, J. H. ;

Olavarria, E. ;

Niederwieser, D. ;

Bacigalupo, A. ;

Barbui, T. ;

Rambaldi, A. ;

Mesa, R. ;

Tefferi, A. ;

Griesshammer, M. ;

Gupta, V. ;

Harrison, C. ;

Alchalby, H. ;

Vannucchi, A. M. ;

Cervantes, F. ;

Robin, M. ;

Ditschkowski, M. ;

Fauble, V. ;

McLornan, D. ;

Ballen, K. ;

Popat, U. R. ;

Passamonti, F. ;

Rondelli, D. ;

Barosi, G. .

LEUKEMIA, 2015, 29 (11) :2126-2133

[58] Monitoring of the JAK2-V617F mutation by highly sensitive quantitative real-time PCR after allogeneic stem cell transplantation in patients with myelofibrosis [J].

Kroeger, Nicolaus ;

Badbaran, Anita ;

Holler, Ernst ;

Hahn, Joachim ;

Kobbe, Guido ;

Bornhaeuser, Martin ;

Reiter, Andreas ;

Zabelina, Tatjana ;

Zander, Axel R. ;

Fehse, Boris .

BLOOD, 2007, 109 (03) :1316-1321

[59] JAK2-V617F-triggered preemptive and salvage adoptive immunotherapy with donor-lymphocyte infusion in patients with myelofibrosis after allogeneic stem cell transplantation [J].

Kroeger, Nicolaus ;

Alchalby, Haefaa ;

Klyuchnikov, Evgeny ;

Badbaran, Anita ;

Hildebrandt, York ;

Ayuk, Francis ;

Bacher, Ulrike ;

Bock, Oliver ;

Kvasnicka, Michael ;

Fehse, Boris ;

Zander, Axel .

BLOOD, 2009, 113 (08) :1866-1868

[60] Mayo CALR mutation type classification guide using alpha helix propensity [J].

Lasho, Terra L. ;

Finke, Christy M. ;

Tischer, Alexander ;

Pardanani, Animesh ;

Tefferi, Ayalew .

AMERICAN JOURNAL OF HEMATOLOGY, 2018, 93 (05) :E128-E129

← 1 2 3 4 5 6 7 8 9 10 →